Get the Stockscreener App
19.22
1.59%
0.30
Pre-market:
19.40
0.18
+0.94%
Staar Surgical Co stock is traded at $19.22, with a volume of 1.88M.
It is up +1.59% in the last 24 hours and up +9.58% over the past month.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
See More
Previous Close:
$18.92
Open:
$17.67
24h Volume:
1.88M
Relative Volume:
1.24
Market Cap:
$948.81M
Revenue:
$230.59M
Net Income/Loss:
$-96.37M
P/E Ratio:
-9.8207
EPS:
-1.9571
Net Cash Flow:
$-39.54M
1W Performance:
-4.52%
1M Performance:
+9.58%
6M Performance:
-30.81%
1Y Performance:
+8.28%
1-Day Range:
$17.56
$19.44
1-Week Range:
$17.56
$20.38
52-Week Range:
$14.69
$30.81
Staar Surgical Co Stock (STAA) Company Profile
Name
Staar Surgical Co
Sector
Industry
Phone
(626) 303-7902
Address
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
19.22 | 934.00M | 230.59M | -96.37M | -39.54M | -1.9571 |
|
ISRG
Intuitive Surgical Inc
|
501.18 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.49 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
84.27 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.05 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
42.88 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-03-26 | Initiated | Wedbush | Neutral |
| Jan-16-26 | Resumed | Morgan Stanley | Underweight |
| Apr-21-25 | Initiated | Wells Fargo | Equal Weight |
| Feb-12-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-12-25 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-25 | Downgrade | Mizuho | Outperform → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-11-24 | Upgrade | BTIG Research | Neutral → Buy |
| Mar-11-24 | Upgrade | Stifel | Hold → Buy |
| Dec-05-23 | Downgrade | Needham | Buy → Hold |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-03-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jun-07-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-17-23 | Initiated | Piper Sandler | Neutral |
| Feb-06-23 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-28-22 | Reiterated | BTIG Research | Buy |
| Dec-08-22 | Initiated | Stifel | Hold |
| Nov-07-22 | Upgrade | Sidoti | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-28-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-09-21 | Initiated | Oppenheimer | Perform |
| Jan-19-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-26-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-31-20 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-20 | Reiterated | The Benchmark Company | Buy |
| Jul-06-20 | Downgrade | Sidoti | Buy → Neutral |
| Jun-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-15-20 | Initiated | Jefferies | Buy |
| Dec-04-19 | Initiated | BTIG Research | Buy |
| Sep-24-18 | Reiterated | The Benchmark Company | Buy |
| Aug-06-18 | Resumed | The Benchmark Company | Buy |
| Nov-20-17 | Reiterated | The Benchmark Company | Buy |
| Aug-14-17 | Reiterated | The Benchmark Company | Buy |
| Mar-03-17 | Reiterated | The Benchmark Company | Buy |
| May-18-16 | Upgrade | The Benchmark Company | Hold → Buy |
| Sep-10-13 | Resumed | The Benchmark Company | Buy |
| Feb-28-13 | Reiterated | The Benchmark Company | Buy |
| Nov-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-12 | Initiated | Northland Securities | Outperform |
| Oct-25-11 | Reiterated | The Benchmark Company | Buy |
| Oct-12-10 | Initiated | Morgan Joseph | Buy |
| May-11-10 | Initiated | Benchmark | Buy |
View All
Staar Surgical Co Stock (STAA) Latest News
STAAR Surgical Releases Q4 and Full Year 2025 Financial Results - VisionMonday.com
STAAR Surgical (STAA) Posts US$80.4 Million Annual Loss Testing Turnaround Narratives - simplywall.st
Needham maintains Hold on STAAR Surgical stock after Q4 miss - Investing.com Nigeria
Staar Surgical Posts Q4 Loss After Rejecting Alcon Deal - Medical Device and Diagnostic industry
Midday Stock Roundup: Evolus, Xponential up - Orange County Business Journal
STAAR Surgical Q4 2025 Earnings Report: Revenue Growth & Analyst OutlookNews and Statistics - IndexBox
STAAR Surgical (NASDAQ:STAA) Shares Gap Down Following Weak Earnings - MarketBeat
STAA Analyst Rating Update: Stifel Lowers Price Target | STAA St - GuruFocus
Stifel Nicolaus Issues Pessimistic Forecast for STAAR Surgical (NASDAQ:STAA) Stock Price - MarketBeat
A Glimpse Into The Expert Outlook On Staar Surgical Through 7 Analysts - Benzinga
Stifel cuts Staar Surgical stock price target on weak Q4 results - Investing.com UK
Stifel cuts Staar Surgical stock price target on weak Q4 results By Investing.com - Investing.com South Africa
Canaccord reiterates Hold on STAAR Surgical stock, $22 target - Investing.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
STAAR Surgical earnings missed by $0.52, revenue topped estimates - Investing.com South Africa
STAAR Surgical (NASDAQ:STAA) Misses Q4 CY2025 Sales Expectations, Stock Drops 11.2% - The Globe and Mail
Staar Surgical Co (STAA) Q4 2025 Earnings Call Highlights: Stron - GuruFocus
STAAR Surgical Q4 2025 Earnings Call Transcript - MarketBeat
STAAR Surgical Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: STAAR Surgical Q4 2025 misses EPS forecast, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: STAAR Surgical Q4 2025 misses EPS forecast, stock dips - Investing.com
Staar Surgical co-CEOs address shareholders, poor Q4 earnings - MassDevice
STAA Reports Lower Q4 Revenue Amidst Inventory Adjustments and M - GuruFocus
Staar Surgical (STAA) Lags Q4 Earnings and Revenue Estimates - Yahoo Finance UK
STAAR Surgical Co reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings Flash (STAA) STAAR Surgical Posts Q4 Loss of $0.37, vs. FactSet Est EPS of $0.04 - marketscreener.com
STAAR Surgical names interim co-CEOs, targets 2026 growth - Investing.com India
STAAR Surgical (NASDAQ:STAA) Issues Earnings Results - MarketBeat
Staar Surgical: Q4 Earnings Snapshot - Bitget
Staar Surgical reports Q4 EPS 0c, consensus 17c - TipRanks
Earnings Breakdown: Staar Surgical Q4 - Benzinga
STAAR Surgical stock plunges 12% on unexpected Q4 loss By Investing.com - Investing.com Australia
STAAR Surgical Company (STAA) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Earnings Flash (STAA) STAAR Surgical Company Reports Q4 Revenue $57.8M, vs. FactSet Est of $75.0M - marketscreener.com
STAAR Surgical stock plunges 12% on unexpected Q4 loss - Investing.com
STAAR Surgical (NASDAQ: STAA) revenue falls in 2025 as China reset widens losses - Stock Titan
Eye implant maker targets China rebound and older patients in 2026 - Stock Titan
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results - Yahoo Finance Singapore
[10-K] STAAR SURGICAL CO Files Annual Report | STAA SEC FilingForm 10-K - Stock Titan
STAAR Surgical Co. Experiences Evaluation Revision Amidst Fluctuating Market Conditions - Markets Mojo
An Inside Look at the Alcon-STAAR Surgical Deal Collapse - Medical Product Outsourcing
What's Next: Staar Surgical's Earnings Preview - Benzinga
STAAR Surgical Company (NASDAQ:STAA) Short Interest Update - MarketBeat
STAAR Surgical Co. Hits Day High with 11.2% Surge in Stock Price - Markets Mojo
STAA SEC FilingsStaar Surg 10-K, 10-Q, 8-K Forms - Stock Titan
STAA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
STAAR Surgical reaches 4 million lens sales milestone By Investing.com - Investing.com Australia
STAAR Surgical reaches 4 million lens sales milestone - Investing.com
STAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction - ChartMill
STAAR Surgical (NASDAQ:STAA) Trading Up 8.4%Here's What Happened - MarketBeat
STAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026 - marketscreener.com
Staar Surgical Co Stock (STAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.58%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):